lintuzumab
teplizumab
pegol
ziltivekimab
antimonoclonal
ozogamicin
carlumab
panitumumab
-mab
drozitumab
inotuzumab ozogamicin
agonistic monoclonal antibody
monoantibody
lexatumumab
polyclonal
bococizumab
-xizu-
cibisatamab
hyperimmunoglobulin
immunoglobulin E
sibrotuzumab
chromobody
atezolizumab
alacizumab
immunoadsorbent
oportuzumab monatox
durvalumab
lucatumumab
-lim-
polyantigenic
dalotuzumab
tabalumab
antisubstance
multiantigenic
xenoantibody
glucoincretin
nofetumomab
aritox
immunoantigen
horseradish peroxidase
ABO antibodies
-toxa-
antihuman
pritumumab
brentuximab
faralimomab
heterophile antibody
heterophil antibody
Forssman antibody
seroconversion